Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VAIL, Colo., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Each July, Steadman Philippon Research Institute (SPRI) and The Steadman Clinic pause to honor a time-honored tradition—celebrating the accomplishments...
-
WASHINGTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ROBERT G. MEYER and THOMAS W.MIARS, IN THE CIRCUIT COURT FOR BALTIMORE CITY, MARYLANDPlaintiffs,Case No.: 24-C-23-003628v. MICHAEL WEIL, LISA...
-
Stuttgart, Germany, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Home Comfort division almost doubles to more than eight billion euros in sales and over 25,000 associates.Increasing demand for cooling...
-
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR SECOND QUARTER/FIRST HALF YEAR | 2025 Q2 2025 sales of CHF 968 million were flat in local currencies1, as growth in Catalysts and Adsorbents &...
-
FRISCO, TX, July 30, 2025 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE; NYSE Texas: CRK) today reported financial and operating results for the quarter ended...
-
AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Round Barn Labs (RBL), a leader in affiliate and influencer marketing for tech brands like Future Fitness, Atlassian, Grammarly, Wyze, Remote, and...
-
Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds...
-
Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for the first six months of 2025 and updated full-year sales and...
-
Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "United States Bakeware Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
-
Pending European Commission (EC) approval, Alhemo® will become available to all adult and paediatric patients 12 years and older living with severe haemophilia A and moderate or severe haemophilia B...